The protective effect of peroxiredoxin II on oxidative stress induced apoptosis in pancreatic β-cells

Cell & Bioscience

Qinghua Wang¹  Fang Zhao¹ 

[1] Department of Physiology, University of Toronto, Toronto, ON, Canada

关键词: Oxidative stress;    Peroxiredoxin 2;    Apoptosis;    β-cells;   

Others  :  793390
DOI  :  10.1186/2045-3701-2-22

 received in 2012-04-12, accepted in 2012-06-18,  发布年份 2012

【 摘 要 】

Excessive loss of pancreatic β-cells, mainly through apoptosis, contributes to the development of diabetic hyperglycemia. Oxidative stress plays a major role in the process of β-cell apoptosis due to low expression level of endogenous antioxidants in the β-cells. Peroxiredoxins (PRDX) are a family of peroxide reductases which uses thioredoxin to clear peroxides. Several members of PRDX have been found in β-cells and recent studies suggested that these antioxidant enzymes possess protective effects in β-cells against oxidative stress mediated apoptosis. In this study, we aimed to investigate the role of PRDX2 in modulating β-cell functions. We detected the expression of PRDX2 both at the transcript and protein levels in the clonal β-cells INS-1 and MIN6 as well as rodent islets. Western blot showed that treatment of MIN6 β-cell line with proinflammatory cytokines, palmitic acid or streptozotocin dose- or time-dependently increased apoptosis, which was associated with reduced endogenous expression levels of PRDX2. To examine the role for PRDX2 in the apoptotic stimuli-induced β-cell apoptosis, we used plasmid overexpression and siRNA knockdown strategies to investigate whether the elevation or knockdown of PRDX2 affects stimuli-induced apoptosis in the β-cells. Remarkably, overexpression of PRDX2 in MIN6 cells significantly attenuated the oxidative stresses mediated apoptosis, as evaluated by cleaved caspase 3 expression, nuclear condensation and fragmentation, as well as FACS analysis. Conversely, attenuation of PRDX2 protein expression using siRNA knockdown exaggerated the cell death induced by proinflammatory cytokines and palmitic acid in the MIN6 cells. These results suggest that PRDX2 may play a protective role in pancreatic β-cells under oxidative stress.

【 授权许可】

   
2012 Zhao and Wang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Drews G, Krippeit-Drews P, Dufer M: Oxidative stress and beta-cell dysfunction. Pflugers Arch 2010, 460:703-718.
• [2]Kim HS, Lee MS: Role of innate immunity in triggering and tuning of autoimmune diabetes. Curr Mol Med 2009, 9:30-44.
• [3]Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW: Beta cell apoptosis in diabetes. Apoptosis 2009, 14:1389-1404.
• [4]Araki E, Oyadomari S, Mori M: Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood) 2003, 228:1213-1217.
• [5]Sivitz WI, Yorek MA: Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 2010, 12:537-577.
• [6]Schattenberg JM, Worns MA, Zimmermann T, He YW, Galle PR, Schuchmann M: The role of death effector domain (DED)-containing proteins in acute oxidative cell injury in hepatocytes. Free Radic Biol Med 2012, 52(9):1911-7.
• [7]Das J, Sil PC: Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids [Epub ahead of print] 2012.
• [8]Low FM, Hampton MB, Winterbourn CC: Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal 2008, 10:1621-1630.
• [9]Gehrmann W, Elsner M, Lenzen S: Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells. Diabetes Obes Metab 2010, 12 Suppl 2:149-158.
• [10]Lenzen S, Drinkgern J, Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996, 20:463-466.
• [11]Szabadkai G, Duchen MR: Mitochondria mediated cell death in diabetes. Apoptosis 2009, 14:1405-1423.
• [12]Bonner-Weir S: Life and death of the pancreatic beta cells. Trends Endocrinol Metab 2000, 11:375-378.
• [13]Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E, Angstetra E, Trapani JA, Santamaria P, Lew AM, Kay TW: Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 2006, 55:2412-2418.
• [14]Eizirik DL, Mandrup-Poulsen T: A choice of death–the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44:2115-2133.
• [15]Schonfeld P, Wojtczak L: Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic Biol Med 2008, 45:231-241.
• [16]Tjälve H: Streptozotocin: distribution, metabolism and mechanisms of action. Uppsala J Med Sci Suppl 1983, 39:145-157.
• [17]Ishrat T, Khan MB, Hoda MN, Yousuf S, Ahmad M, Ansari MA, Ahmad AS, Islam F: Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 2006, 171:9-16.
• [18]Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M, Kawada J: Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic beta-cells. FEBS Lett 1988, 239:295-298.
• [19]Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T: Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation. Diabetes 1991, 40:1141-1145.
• [20]Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M, Kawada J: Enhancement by streptozotocin of O2- radical generation by the xanthine oxidase system of pancreatic beta-cells. FEBS Lett 1988, 239:295-298.
• [21]Chae HZ, Kim IH, Kim K, Rhee SG: Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem 1993, 268:16815-16821.
• [22]Robinson MW, Hutchinson AT, Dalton JP, Donnelly S: Peroxiredoxin: a central player in immune modulation. Parasite Immunol 2010, 32:305-313.
• [23]Zhang B, Wang Y, Su Y: Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009, 286:154-160.
• [24]ten Berge D, Brouwer A, Korving J, Reijnen MJ, van Raaij EJ, Verbeek F, Gaffield W, Meijlink F: Prx1 and Prx2 are upstream regulators of sonic hedgehog and control cell proliferation during mandibular arch morphogenesis. Development 2001, 128:2929-2938.
• [25]Yan Y, Sabharwal P, Rao M, Sockanathan S: The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2. Cell 2009, 138:1209-1221.
• [26]Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG: Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998, 273:6297-6302.
• [27]Yang S, Luo A, Hao X, Lai Z, Ding T, Ma X, Mayinuer M, Shen W, Wang X, Lu Y, Ma D, Wang S: Peroxiredoxin 2 Inhibits Granulosa Cell Apoptosis During Follicle Atresia Through the NFKB Pathway in Mice. Biol Reprod 2011, 84(6):1182-9.
• [28]Chen J, Gan Y, Ji X, Hu X, Luo Y, Zhang L, Li P, Liu X, Yan F, Vosler P, Gao Y, Stetler RA: Transgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathway. Antioxid Redox Signal [Epub ahead of print] 2012.
• [29]Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y, Signore A, Zhu J, Hastings T, Greenamyre JT, Chen J: Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 2011, 31:247-261.
• [30]Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004, 101:6062-6067. %20
• [31]Matte A, Low PS, Turrini F, Bertoldi M, Campanella ME, Spano D, Pantaleo A, Siciliano A, De FL: Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radic Biol Med 2010, 49:457-466.
• [32]Meier JJ: Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008, 51:703-713.
• [33]Wang Q, Jin T: The role of insulin signaling in the development of beta-cell dysfunction and diabetes. Islets 2009, 1:95-101.
• [34]Lee MS, Chang I, Kim S: Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 2004, 83:82-92.
• [35]Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Pugazhenthi S, Reusch J, Kench J: Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003, 1005:43-54.
• [36]Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002, 45:85-96.
• [37]Bast A, Wolf G, Oberbaumer I, Walther R: Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002, 45:867-876.
• [38]Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Theatre E, Verhaeghe C, Magnusson NE, Chariot A, Orntoft TF, Eizirik DL: Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells. Diabetologia 2008, 51:1213-1225.
• [39]Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, Grieco FA, Dotta F, Weir GC, Marchetti P, Eizirik DL, Cnop M: Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 2010, 53:1395-1405.
• [40]Han YH, Kwon JH, Yu DY, Moon EY: Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence. Free Radic Res 2006, 40:1182-1189.
• [41]Wolf G, Aumann N, Michalska M, Bast A, Sonnemann J, Beck JF, Lendeckel U, Newsholme P, Walther R: Peroxiredoxin III protects pancreatic β-cells from apoptosis. J Endocrinol 2010, 207:163-175.
• [42]Aktan F: iNOS-mediated nitric oxide production and its regulation. Life Sci 2004, 75:639-653.
• [43]Hynes SO, McCabe C, O'Brien T: beta cell protection by inhibition of iNOS through lentiviral vector-based strategies. Methods Mol Biol 2011, 704:153-168.
• [44]Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742.
• [45]Cnop M: Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 2008, 36:348-352.
• [46]Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF: Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 2011, 300:E255-E262.
• [47]Lang F, Ullrich S, Gulbins E: Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 2011, 15:1061-1071.
• [48]Higa M, Shimabukuro M, Shimajiri Y, Takasu N, Shinjyo T, Inaba T: Protein kinase B/Akt signalling is required for palmitate-induced beta-cell lipotoxicity. Diabetes Obes Metab 2006, 8:228-233.
• [49]Shimabukuro M, Ohneda M, Lee Y, Unger RH: Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997, 100:290-295.
• [50]Saitoh Y, Chun-ping C, Noma K, Ueno H, Mizuta M, Nakazato M: Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells. Diabetes Obes Metab 2008, 10:564-573.
• [51]Zhang N, Kumar M, Xu G, Ju W, Yoon T, Xu E, Huang X, Gaisano H, Peng C, Wang Q: Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 2006, 49:506-518.
• [52]Xu E, Kumar M, Zhang Y, Ju W, Obata T, Zhang N, Liu S, Wendt A, Deng S, Ebina Y, Wheeler MB, Braun M, Wang Q: Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006, 3:47-58.
• [53]Zhang N, Kumar M, Xu G, Ju W, Yoon T, Xu E, Huang X, Gaisano H, Peng C, Wang Q: Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 2006, 49:506-518.
• [54]Xu E, Kumar M, Zhang Y, Ju W, Obata T, Zhang N, Liu S, Wendt A, Deng S, Ebina Y, Wheeler MB, Braun M, Wang Q: Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006, 3:47-58.
• [55]Wang Q, Chen K, Liu R, Zhao F, Gupta S, Zhang N, Prud'homme GJ: Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist. PLoS One 2010, 5:e12734.